KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Inventory (2016 - 2025)

Exact Sciences (EXAS) has disclosed Inventory for 12 consecutive years, with $166.2 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 2.35% to $166.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $166.2 million through Dec 2025, up 2.35% year-over-year, with the annual reading at $166.2 million for FY2025, 2.35% up from the prior year.
  • Inventory for Q4 2025 was $166.2 million at Exact Sciences, up from $164.8 million in the prior quarter.
  • The five-year high for Inventory was $176.6 million in Q1 2025, with the low at $89.0 million in Q1 2021.
  • Average Inventory over 5 years is $129.5 million, with a median of $127.4 million recorded in 2023.
  • The sharpest move saw Inventory dropped 2.6% in 2024, then surged 37.38% in 2025.
  • Over 5 years, Inventory stood at $105.0 million in 2021, then grew by 12.63% to $118.3 million in 2022, then increased by 7.79% to $127.5 million in 2023, then grew by 27.38% to $162.4 million in 2024, then rose by 2.35% to $166.2 million in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $166.2 million, $164.8 million, and $171.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.